Trial bolsters evidence that less invasive strategy is safe and effective in younger, lower-risk patients
News | Cardiovascular Clinical Studies
TAVR Found Non-Inferior to SAVR for Low-Risk Patients

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
Results from the IVUS-DCB trial were recently presented at the American College of Cardiology Annual Scientific Session, ACC.24.
News | ACC
Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment

April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were ...

Home April 11, 2024
Home
PCI shows substantial benefits over medications alone
News | Cardiovascular Clinical Studies
Preventive Percutaneous Coronary Intervention for High-Risk Coronary Plaques Reduces Cardiac Events

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
AMA survey finds economic, patient-care impact of Change Healthcare cyber-attack ongoing
News | Cybersecurity
Life After Change Cyber-attack: Without Payment for Claims, Physicians Struggle to Keep Practices Afloat

April 10, 2024 — The American Medical Association (AMA) released informal survey findings (PDF) showing the ongoing ...

Home April 10, 2024
Home
A new technology using ultralow temperature cryoablation (ULTC), developed by Adagio Medical, has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science was presented this week during EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).
News | ESC
Cryocure-VT Trial Outcomes Presented in EHRA 2024 Late-Breaking Science Session

April 10, 2024 — A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular ...

Home April 10, 2024
Home
An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
News | ESC
News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

April 10, 2024 — An international consensus statement on how to treat atrial fibrillation with catheter or surgical ...

Home April 10, 2024
Home
Study found no difference in troponin biomarkers up to one month after anthracycline treatment
News | Cardiovascular Clinical Studies
ACE Inhibitor Not Protective Against Heart Damage from Chemotherapy

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as the organization’s first non-physician president.
News | Cardiovascular Business
Cathie Biga is New American College of Cardiology President

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
UC Davis is one of the first sites nationwide to treat tricuspid regurgitation using a minimally invasive catheter system
News | Structural Heart
Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device

April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with ...

Home April 09, 2024
Home
Subanalysis finds benefit for patients not on heart-beneficial antidiabetic medication
News | Cardiovascular Clinical Studies
New Drug Fails to Improve Diabetes-Related Heart Failure

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
Phase 2 trial shows early signs that the investigational drug could relieve symptoms and improve exercise capacity in HCM patients with no other evidence-based treatment options available
News | Cardiovascular Clinical Studies
Ninerafaxstat Well-Tolerated and Safe for Nonobstructive Hypertrophic Cardiomyopathy

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
Trial shows increased risk of bleeding with topical administration during open heart surgery
News | Cardiovascular Clinical Studies
Topical Tranexamic Acid Found Inferior to Intravenous Administration

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
Participants saw 35% reduction in LDL cholesterol, signaling the process could offer safe, effective non-prescription use of life-saving drug
News | Cardiovascular Clinical Studies
Study Shows Web App Effective in Determining Access to Statins Without a Prescription

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
First head-to-head comparison of leading valve types finds better valve performance with selfexpanding valve and non-inferior clinical outcomes at one year
News | Cardiovascular Clinical Studies
Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
Infusions reduce lead levels but show no effect on clinical endpoints
News | Cardiovascular Clinical Studies
Chelation Therapy Does Not Improve Outcomes after Heart Attack

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now